Buys
Open market- Shares
- Avg price
- Total value
Mohan Bala - SVP, Chief Development at Mersana Therapeutics, Inc.
Issuer-level insider activity
- Role
- SVP, Chief Development
- Issuer ticker
- MRSN
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Mohan Bala in Mersana Therapeutics, Inc.
Sells
Open market- Shares
- -77
- Avg price
- $9.90
- Total value
- -$762
Net
Past year- Shares
- -77
- Share %
- -100%
- Total value
- -$762
Reported holdings for Mohan Bala in Mersana Therapeutics, Inc.
Form 4 holding
SVP, Chief Development
Mersana Therapeutics, Inc.
- Security class
- Restricted Stock Unit
- Shares / value
- 0
- Estimated value
- $39,375
- Report date
- 25 Oct 2025
- Price
- $0.6300
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
SVP, Chief Development
Mersana Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 06 Jan 2026
- Price
- $28.14
- Ownership
- Direct
Form 4 holding
SVP, Chief Development
Mersana Therapeutics, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 0
- Estimated value
- Report date
- 06 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
SVP, Chief Development
Mersana Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 06 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Mohan Bala in Mersana Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.